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Targeted genome editing with engineered nucleases
has transformed the ability to introduce precise
sequence modifications at almost any site within
the genome. A major obstacle to probing the effi-
ciency and consequences of genome editing is that
no existingmethod enables the frequency of different
editing events to be simultaneouslymeasured across
a cell population at any endogenous genomic
locus. We have developed a method for quantifying
individual genome-editing outcomes at any site of in-
terest with single-molecule real-time (SMRT) DNA
sequencing. We show that this approach can be
applied at various loci using multiple engineered
nuclease platforms, including transcription-acti-
vator-like effector nucleases (TALENs), RNA-guided
endonucleases (CRISPR/Cas9), and zinc finger
nucleases (ZFNs), and in different cell lines to identify
conditions and strategies in which the desired engi-
neering outcome has occurred. This approach offers
a technique for studying double-strand break repair,
facilitates the evaluation of gene-editing technolo-
gies, and permits sensitive quantification of editing
outcomes in almost every experimental system used.INTRODUCTION
Genome editing with engineered nucleases is a transformative
technology for efficiently modifying essentially any genomic
sequence of interest (McMahon et al., 2012). This technology uti-
lizes engineered nucleases to generate site-specific double-
strand breaks (DSBs) at desired genomic locations followed by
resolution of DSBs using the endogenous cellular repair mecha-
nisms of nonhomologous end-joining (NHEJ) and homology
directed repair (HDR) (Porteus and Carroll, 2005). A variety
of desired genetic modifications can be achieved with this
approach, including mutation of a specific site through muta-
genic NHEJ and precise change of a genomic sequence to anew sequence through HDR. There are currently four principal
families of engineered nucleases used for gene editing: Zinc
Finger Nucleases (ZFNs) (Porteus and Carroll, 2005), Transcrip-
tion Activator-Like Effector Nucleases (TALENs) (Bogdanove
and Voytas, 2011), Clustered Regularly Interspaced Short Palin-
dromic Repeats (CRISPR/Cas9) or RNA-guided endonucleases
(hereafter called ‘‘RGENs’’) (Gaj et al., 2013; Mali et al., 2013),
and engineered meganucleases (Silva et al., 2011). The rapid
development of these technologies is allowing for the precise
alteration of genomes for numerous applications, including plant
engineering (Li et al., 2012), generation of cell lines for basic
science (Soldner et al., 2011), human gene therapy (Urnov
et al., 2005), and industrial applications (Fan et al., 2012).
When a new set of gene-editing reagents is developed for a
custom application, the activity levels of nucleases and the fre-
quency of the desired gene-editing event at the target locus
must be determined and often need to be optimized for the spe-
cific cell type and system being used. This need has previously
been met by a variety of methods including gel-based assays
to measure mutagenic NHEJ (Guschin et al., 2010), gene
addition of fluorescent reporters to measure HDR (Porteus and
Baltimore, 2003; Stark et al., 2004), analysis of large numbers
of single-cell clones, and the use of optimization assays to mea-
sure NHEJ and HDR at engineered reporter loci (Certo et al.,
2011). Although each of these assays have their utility, each
have important limitations including a lack of sensitivity required
for difficult applications (gel-based assays), the use of an indirect
rather than a direct measure of genome editing (targeted gene
addition of fluorescent reporters), and the need to generate re-
porter cell lines (Traffic Light Reporter system). The Traffic Light
Reporter (TLR) system (Certo et al., 2011) is the only one of these
assays that allows simultaneous measurement of NHEJ and
HDR by expressing GFP in cells that undergo HDR-mediated
correction of a GFP gene and expressing mCherry in cells
with NHEJ-induced frameshift mutations. Although the TLR is a
very sensitive assay for measuring DSB repair (DSBR) pathway
choice, the need to generate a fluorescent reporter locus pre-
cludes measurement at endogenous target loci and thus far
has prevented the use of the TLR in human primary cells. High-
throughput sequencing of endogenous loci overcomes these
limitations, but the range of outcomes that can be measured
is limited by sequencing read lengths. Illumina (Yang et al.,Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authors 293
2013b) and 454 (Qi et al., 2013) sequencing have recently been
used to measure HDR and NHEJ outcomes when single-
stranded oligodeoxynucleotides (ssODNs) or plasmids with
short homology arms are used as donor templates, but the
read-length limitations of these platforms do not allow analysis
of longer arms of homology that drive more efficient HDR and
provide the flexibility to target long gene cassettes.
Here, we present a method for measuring genome-editing
outcomes at endogenous loci using single-molecule real-time
(SMRT) DNA sequencing, which provides read lengths ap-
proaching 15 kb and is an affordable approach that can be
widely used. This technique allows for analysis of gene-editing
frequencies when donor templates with long arms of homology
are used, which is a common strategy to increase HDR effi-
ciency in primary cells and for the addition of large gene inserts.
Using this method, we were able to measure simultaneous
frequencies of NHEJ and HDR in primary cells and cell lines
with greatly improved detection sensitivity. We describe the
use of SMRT sequencing analysis to measure genome-editing
outcomes and rare large insertions generated by TALENs,
ZFNs, and RGENs at the endogenous IL2RG, HBB, and CCR5
loci. In addition, we use this system to quantify the effect of
varying different parameters on the frequency of different
gene-editing outcomes.
RESULTS
Measurement of Gene-Editing Outcomes at the
Endogenous IL2RG Locus
To develop amethod for quantitatively and rapidlymeasuring the
different gene alterations occurring at an endogenous locus of
interest, we used a highly active TALEN pair to stimulate DSBs
at the endogenous IL-2 receptor common g-chain gene
(IL2RG), mutations in which are responsible for the congenital
primary immunodeficiency SCID-X1 (Kildebeck et al., 2012;
Shaw and Kohn, 2011). For the introduction of precise sequence
alterations at this locus, we designed a donor template with
approximately 400 bp arms of homology 50 and 30 of the TALEN
cut site (Figure 1A). Within the 30 arm of homology, we introduced
seven point mutations that, upon successful HDR, are stably in-
tegrated into the IL2RG gene and prevent binding and cleavage
by the TALEN pair (Figures 1A and 1B). To measure the fre-
quency of mutagenic NHEJ and HDRwith this system, we devel-
oped a strategy based on single-molecule real-time (SMRT) DNA
sequencing, a high-throughput sequencing technology capable
of analyzing long DNA fragments. First, the IL2RG locus was
amplified using a forward primer that is 50 and outside the start
of the 50 homology arm and a reverse primer that is downstream
of the TALEN pair target site (Figure 1C). With this approach,
nonintegrated and randomly integrated donor templates are
not amplified, removing common sources of background noise.
The SMRT DNA sequencing technology allows for the determi-
nation of DNA sequence from individual DNA templates (Eid
et al., 2009; Roberts et al., 2013). Single-molecule read lengths
approaching 15 kb were reached in this study, with an average
read length approaching 3 kb. For DNA fragments shorter than
the read limit of the polymerase, improved sequence accuracy
(frequently reaching an average Phred QV score of 40, denoting294 Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authors99.99% accuracy) is achieved by iteratively sequencing the
same circular DNA template (Travers et al., 2010) (Figure 1C).
To induce sequence alterations in IL2RG, we expressed the
IL2RG TALENs from plasmid DNA with or without introduction
of donor DNA and then analyzed cell populations by SMRT
DNA sequencing. Following transfection with TALENs alone,
we detected unmodified alleles and alleles with deletions or in-
sertions indicative of mutagenic NHEJ (Figure 1D). When cells
were transfected with both the TALENs and donor DNA, we de-
tected unmodified alleles, alleles with deletions or insertions, and
alleles with the seven point mutations precisely integrated into
IL2RG by HDR. Notably, no alleles were detected with both the
seven point mutations and indels indicative of NHEJ, validating
the ability of the point mutations to prevent TALEN cleavage of
HDR-modified alleles. High frequencies of ‘‘on-target’’ IL2RG
modification were observed in K562 cells under these condi-
tions, with 18% of alleles mutated by NHEJ and 17% of alleles
precisely modified by HDR (Figure 1D). Because the PCR strat-
egy being used, where one primer is outside of the donor
template arm of homology, essentially no background signal
was detected from amplification of nonintegrated or randomly
integrated donor template. Control experiments (either mock
or donor only transfections) had low background frequencies
of NHEJ and HDR reads resulting from PCR or DNA sequencing
errors, which ranged from 0.00% to 0.03% for individual sam-
ples with average frequencies of 0.007% NHEJ and 0.001%
HDR (Tables S1–S6). This low level of background noise,
coupled with the high-throughput nature of this approach, pro-
duces a high level of sensitivity and creates possibilities for
studying rare DNA repair events.
Reliability of SMRT Sequencing Analysis at a Single
Endogenous Locus
To validate the accuracy of the SMRT DNA sequencing strat-
egy, we compared our high-throughput results with standard
gel-based assays and single-cell clone analysis of K562 cells.
First, we used a restriction fragment length polymorphism
(RFLP) assay to measure the frequency of HDR by measuring
the presence of an AflII restriction site that is created when
the seven point mutations within the donor template are pre-
cisely incorporated into the target locus (Figure 2A). Using the
RFLP assay, the AflII restriction site was detected in an average
of 14.3% of alleles normalized for transfection efficiency
compared to 16.8% of alleles by SMRT sequencing analysis
of the same populations. The most commonly used methods
for determining the frequency of NHEJ measure any small dele-
tion or insertion events, which is confounded by sequence alter-
ations introduced by HDR. To independently determine the true
frequency of alleles modified by NHEJ and HDR, we grew sin-
gle-cell clones from a representative sample. Analysis of these
clones showed that 11.3% of alleles had undergone mutagenic
NHEJ and 11.1% of alleles had been precisely modified by
HDR, compared to frequencies of 11.2% and 11.0%, respec-
tively, as measured by SMRT sequencing analysis of the
same population (Figure 2B); SMRT frequencies represent the
total population frequency, not normalized to transfection effi-
ciency, in order to directly compare to the clonal analysis. To
confirm the reproducibility of SMRT sequencing analysis, we
Figure 1. Measuring Gene Editing at an Endogenous Locus with SMRT Sequencing
(A) Sequence of the TALEN target site at the IL2RG locus and the IL2RG donor template. The donor template harbors seven point mutations that, when integrated
into IL2RG, create silent mutations and an AflII restriction site. These substitutions alter the right TALEN binding site and provide a signature for alleles precisely
modified by HDR.
(B) Diagram of gene editing at an endogenous locus. TALENs create a double-strand break (DSB), which can lead to no modification, insertion or deletion
mutations, or integration of point mutations from the donor template.
(C) Schematic of SMRT DNA sequencing analysis. The endogenous locus is amplified by PCR, with at least one primer outside the arms of homology of the donor
template, and SMRT adapters are added to PCR amplicons. Individual DNAmolecules are sequenced by SMRT sequencing, with read lengths averaging3 kb in
length and approaching 15 kb.
(D) Measurement of gene-editing outcomes at the IL2RG locus in K562 cells. Modification frequencies are normalized to transfection efficiency.
Data for graph are from Table S1. Bars represent three independent biological replicates; error bars, SD.analyzed a single targeted population eight times and found
SDs for NHEJ and HDR of 0.66% and 0.79%, respectively (Fig-
ure 2C). This experimental variance between samples was only
slightly higher than the expected statistical variance for the
number of sequences analyzed, demonstrating the reliability
of this approach (Figure 2D).Quantification of Gene Editing at the IL2RG Locus in
Primary Cells
For gene-editing applications, moving from known conditions
in commonly used cell lines to more difficult experimental
platforms, such as induced pluripotent stem cells or primary
cells, poses a significant challenge. Using the gene-editing toolsCell Reports 7, 293–305, April 10, 2014 ª2014 The Authors 295
Figure 2. Reliability of SMRT Sequencing Analysis for Measuring Gene-Editing Outcomes at an Endogenous Locus
(A) RFLP analysis of K562 cells targeted with 1 mg of each TALEN and 5 mg donor in triplicate. The frequency of HDR in each sample as measured by RFLP and
SMRT sequencing analysis is shown.
(B) Quantification of NHEJ and HDR frequencies in single-cell clones grown from a representative population of K562 cells. Error bars represent 90% confidence
intervals.
(C) A representative sample of targeted K562 cells was analyzed by SMRT sequencing eight separate times to determine the variability introduced by PCR, SMRT
library synthesis, and sequencing. Error bars represent 90% confidence intervals.
(D) Quantification of the observed experimental variation compared to the expected statistical variation for the number of sequences analyzed for the eight
replicates. Error bars for experimental variation represent SD. Error bars for statistical variation represent 68% confidence intervals (corresponding to the fraction
of the normal distribution covered by ±1 SD).previously described, we next tested our ability to measure
gene-editing events in CD34+ hematopoietic stem/progenitor
cells (HSPCs) and human embryonic stem cells (hESCs), both
of which are difficult to target, but important cell types for basic
research and gene therapy. After introducing TALENs and donor
DNA into CD34+ HSPCs, SMRT sequencing analysis showed
frequencies of mutagenic NHEJ and HDR of 7% and 1%,
respectively, at the endogenous IL2RG locus (Figure 3A). In
hESCs, which commonly require enrichment of targeted clones
due to low gene-editing efficiencies, addition of our gene-editing
reagents resulted in mutagenic NHEJ and HDR frequencies of
0.10% and 0.14%, respectively (Figure 3B). Control hESC sam-
ples transfected with only donor DNA showed background fre-
quencies of 0.02% NHEJ and no HDR, illustrating the very low
level of background noise for this technique. Our transfection296 Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authorsefficiency for these hESC populations was approximately
20%, suggesting that with enrichment for transfected cells we
would generate modification frequencies of 0.5%–0.7%. These
numbers are consistent with the numbers published by Soldner
et al. (2011), who showed that after sorting for highly transfected
hESCs targeting frequencies of 0.4%–0.8% were obtained.
Importantly, because IL2RG is silent in both of these cell types,
these results demonstrate the ability of this approach to provide
quantitative and sensitive measures of gene editing and DNA
damage repair at a silent endogenous locus in primary cells.
Analysis of Gene Editingwith TALENs, RGENs, and ZFNs
at the Endogenous IL2RG, HBB, and CCR5 Loci
The extraordinary expansion of gene-editing technologies
over recent years has created a plethora of opportunities for
Figure 3. Measurement of Genome Editing
at an Endogenous Locus in Human Primary
Cells
(A) Measurement of gene-editing outcomes at
IL2RG in CD34+ HSPCs using the high-expression
TALEN plasmids (Supplemental Experimental
Procedures). Data for graph are from Table S2.
Bars represent three independent biological rep-
licates; error bars, SD.
(B) Measurement of gene-editing outcomes at
IL2RG in hESCs using the high-expression TALEN
plasmids (Supplemental Experimental Pro-
cedures). Data for graph are from Table S3. Bars
represent three independent biological replicates;
error bars, SD.researchers attempting to modify genomes. With the introduc-
tion of TALENs and RGENs, it is now possible to generate
tens to hundreds of candidate nucleases in a matter of weeks,
or even days, and target multiple genomic sites simultaneously
(Briggs et al., 2012; Cong et al., 2013; Kim et al., 2013;
Reyon et al., 2012; Yang et al., 2013a). Via simultaneous
analysis of different genomic sites and conditions in a single
SMRT sequencing run, this approach has the potential
to rapidly expedite the process of characterizing nuclease
activities and optimizing targeting parameters. To determine
the ability of this method to measure the activities of different
classes of nucleases at multiple genomic sites, we treated
cells with TALENs, RGENs, and ZFNs designed to target
the IL2RG, HBB, and CCR5 genes and analyzed gene
modification.
To test the relative activity of TALENs and RGENs at the
IL2RG locus, we first constructed an RGEN with a target site
overlapping the target site of the IL2RG TALENs (Figure 4A).
Expression of the RGEN in K562 cells generated targeted mu-
tations in 37% of IL2RG alleles compared to only 13% of al-
leles using TALENs. Introduction of donor template DNA with
either the RGEN or TALENs produced alleles modified by
mutagenic NHEJ and alleles precisely modified by HDR. As
expected, the more active RGEN stimulated a higher level of
HDR than the TALENs with 33% and 22% of alleles harboring
the integrated SNPs, respectively. Moving to a different
genomic locus, we used a TALEN pair and an RGEN targeting
the HBB gene, mutations in which are responsible for sickle
cell anemia and thalassemia (Gallagher, 2013) (Figure 4B). At
HBB, the RGEN again produced significantly higher fre-
quencies of gene disruption than the TALENs and stimulated
higher frequencies of HDR upon the introduction of donor tem-
plate. When expressed with donor template, the HBB RGEN
mutated 41% of HBB alleles, whereas the IL2RG RGEN
mutated 21% of IL2RG alleles, suggesting that more DSBs
were being created at the HBB locus. Despite this increase
in mutagenesis, the simultaneous level of HDR was only 14%
at HBB compared to 33% at IL2RG. Thus, total modification
levels at HBB and IL2RG were highly similar, 55% and 54%,
respectively, but the ratio of HDR to NHEJ was markedly lower
at HBB (0.34:1) than at IL2RG (1.6:1) (Figures 4A and 4B). This
large difference in the efficiency of precise gene targeting sug-
gests that there could be intrinsic differences between theseloci affecting their ability to participate in plasmid-mediated
gene targeting by HDR.
To further confirm the utility of SMRT sequencing analysis to
measure targeted genomic modifications for multiple classes of
nucleases, we compared the activity of previously reported
ZFNs and TALENs designed to target the CCR5 locus (Musso-
lino et al., 2011; Perez et al., 2008). As seen at IL2RG and HBB,
addition of nucleases led to targeted disruption of the endoge-
nous gene by NHEJ and the further addition of donor template
DNA stimulated targeted integration through HDR (Figure 4C).
The CCR5-specific ZFNs, variants of which are currently being
used in clinical trials for HIV (Perez et al., 2008), produced higher
levels of modification at the endogenous CCR5 locus than
TALENs designed to an overlapping target site. It is important
to note that in this study stable modifications in K562 cells
were measured for TALENs, RGENs, and ZFNs 14 days
posttransfection. The absolute genome-editing frequencies re-
ported here are thus somewhat different than published results
for previously described nucleases where nuclease activity
was measured at different time points, in different cell types,
and with different nuclease levels (Mussolino et al., 2011; Perez
et al., 2008; Voit et al., 2013). Nuclease-induced NHEJ is typi-
cally measured with high nuclease levels 3 days posttransfec-
tion to detect maximal NHEJ levels, but these modifications
decrease over time due to toxicity (Doyon et al., 2010, 2011;
Kim et al., 2009; Lombardo et al., 2007) (Figure S1). Instead of
measuring NHEJ and HDR separately or with different transfec-
tion conditions, SMRT DNA sequencing provides a simple
alternative for comparing stable NHEJ and HDR frequencies
simultaneously.
Optimization of Gene Targeting Parameters
In addition to comparing different nuclease platforms, we have
also used the SMRT DNA sequencing approach to study
different variables that might affect genome-editing outcomes.
To explore how varying the dose of TALENs affects gene-editing
frequencies, we measured frequencies of NHEJ and HDR at
IL2RG while progressively decreasing the amount of TALENs
transfected in K562 cells. Keeping the amount of donor DNA
constant and titrating down the amount of TALENs by 100-
fold, we saw a progressive decrease in both mutagenic NHEJ
and HDR events, whereas their relative frequencies remained
largely unchanged (Figure 5A). Using this approach, we wereCell Reports 7, 293–305, April 10, 2014 ª2014 The Authors 297
Figure 4. Measuring Gene Editing with Different Engineered Nuclease Platforms at Different Genomic Targets
(A) Left: IL2RG target site for TALENs and RGEN guide sequence. The IL2RG start codon is shown in green. Right: modification of the IL2RG locus in K562 cells.
Data for graph are from Table S4.
(B) Left: HBB target site for TALENs and RGEN guide sequence. The HBB start codon is shown in green. Right: modification of the HBB locus in K562 cells. Data
for graph are from Table S5.
(C) Left: CCR5 target site for TALENs and ZFNs in exon 3. Right: modification of the CCR5 locus in K562 cells. Data for graph are from Table S6. For CelI Assay
results, see also Figure S1. Bars represent three independent biological replicates; error bars, SD.able to reliably detect gene-editing outcomes at frequencies
ranging from >20% at high TALEN levels to%0.1% at very low
TALEN levels. Even at modification frequencies of 0.1%–0.4%,
relative activity levels were easily distinguished with this
approach (Table S7). Next, to test conditions for maximizing
the frequency of HDR at IL2RG, we investigated the effect of
the amount of donor template DNA on gene modification. Keep-
ing the amount of TALENs constant and titrating the amount of
donor DNA, we saw the overall level of modification at IL2RG298 Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authorsremain relatively constant, whereas the total level of HDR rose
from 1.6% to 17.8% at optimal levels (Figure 5B; Table S8).
With this rise in the contribution of HDR, the ratio of HDR to
NHEJ increased from 0.12 to 1.37 with increasing abundance
of donor DNA (Figure 5C).
Another important variable for efficient HDR-mediated DNA
repair is the length of the homologous regions in donor DNA,
which has been shown to vary between species and in different
cell types of the same species (Beumer et al., 2013; Orlando
Figure 5. Optimization of Gene-Editing Parameters at IL2RG with SMRT Sequencing
(A) Titration of TALEN amount in K562 cells with amount of donor DNA held constant at 5 mg. Data for graph are from Table S7.
(B) Titration of donor DNA amount in K562 cells with TALEN DNA amount held constant at 1 mg each TALEN. Data for graph are from Table S8.
(C) Ratio of HDR to NHEJ for samples in (B).
(D) Left: schematic of donor templates with varying arm of homology lengths. Right: quantification of effect of homology arm length on gene-editing frequencies in
K562 cells. Data for graph are from Table S9. Bars represent three independent biological replicates; error bars, SD.et al., 2010; Waldman, 2008). To determine the effect of homol-
ogy arm length on HDR efficiency with plasmid donors, we con-
structed a series of donor templates with a range of homology
arm lengths from 800 to 100 bp (Figure 5D; Table S9). At the
IL2RG locus in K562 cells, homology arms 100 or 200 bp in
length were found to be significantly less effective for HDR
than plasmid donor templates with 400 or 800 bp homology
arms. As would be predicted, the homology arm length did notchange the frequency of mutagenic NHEJ. In this cell type,
400 bp arms of homology actually resulted in the same levels
of HDR as more commonly used 800 bp arms, suggesting that
for gene targeting in some human cell types maximal levels of
HDR may be achieved with relatively short 400 bp arms of
homology. For all areas of optimization, however, the specific
setting of the cell type and the chromosomal locus under inves-
tigation should be taken into consideration.Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authors 299
SMRT Sequencing of Genome-Editing Outcomes
Reveals Genomic and Plasmid DNA Sequences
Captured into Targeted Sites
A unique feature of the SMRT sequencing method is the combi-
nation of high-throughput with long sequence read lengths. This
combination allowed us to see rare mutations including large in-
sertions and deletions hundreds of base pairs (bp) in length.
Analysis of mutations at the IL2RG,HBB, andCCR5 loci showed
a wide range of insertions and deletions ranging from +334
to 412 bp. Interestingly, when we BLASTed the inserted se-
quences that were >30 bp against NCBI nonredundant nucleo-
tide databases, we were able to identify sequences originating
from the same chromosome as the target site, nonhomologous
chromosomes, plasmid DNA, and the E. coli genome. Repre-
sentative samples of such insertion events can be seen in Fig-
ure 6. At each end of an insertion event, there is a junction
with the chromosomal segment on one side and the inserted
segment on the other side. Processing of the chromosomal
sides of the junctions can be tracked by examining the se-
quences at these sites. NHEJ-mediated DSBR commonly
involves deletion of a few nucleotides. Surprisingly, of the 42
long insertions we found only seven that involved deletions of
nucleotides. The remaining 35 did not involve even single-nucle-
otide deletions. This finding suggests that the insertion event
may have a role in protecting chromosomes from harmful dele-
tions during DSBR. Microhomology is known to drive some
small insertion and deletion events during NHEJ. Analysis of
the sequences flanking the external sources of these long inser-
tion events did not reveal any trends, suggesting that these
events were not driven by flanking microhomologous sequences
(Supplemental Results).
DISCUSSION
Although the simplicity and flexibility of engineering TALENs and
RGENs has transformed gene editing over recent years, many
questions remain about DSBR processes and gene targeting in
different cell types and at different genomic sites. Here, we pre-
sent a rapid, accurate, and sensitive strategy for analyzing gene-
editing outcomes and DSBR pathway choice at endogenous
loci in potentially any cell type using any type of engineered
nuclease. The SMRT DNA sequencing strategy offers three prin-
cipal advantages over currently available techniques: (1) sensi-
tive measurement of genome editing in any cell type, including
primary stem cells, without the need to make a stable reporter
cell line, (2) measurement of modifications at endogenous loci
regardless of transcriptional status, and (3) long sequencing
read lengths that allow insight into a wide range of DNA repair
outcomes when donor templates with long arms of homology
are used.
Without generating reporter cell lines, we used the SMRT DNA
sequencing strategy to measure gene-editing outcomes in
CD34+ HSPCs, hESCs, and K562 cells. Measurement at the
IL2RG locus was not inhibited by the lack of transcription of
this gene in CD34+ HSPCs and hESCs, demonstrating the ability
of this method to provide quantitative and sensitive analysis of
silent endogenous loci. Epigenetic status is known to affect all
DNA-metabolism processes including transcription, replication,300 Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authorsand repair (Cavalli and Misteli, 2013; Papamichos-Chronakis
and Peterson, 2013). The importance of transcriptional activa-
tion and epigenetic status for gene-editing efficiency is still
largely unknown, but epigenetic modification was recently
shown to impact DSBR pathway choice (Daboussi et al., 2012;
Kuhar et al., 2014; Valton et al., 2012a, 2012b; van Rensburg
et al., 2013). The SMRT DNA sequencing strategy could be
used to further study how chromatin status influences DSBR
pathway choice and gene-editing efficiency by providing anal-
ysis in a broader range of cell types in which the chromatin state
of the targeted site is known. One other potentially important
variable for gene-editing efficiency, particularly when working
between different cell types, is the method of delivery, and this
strategy could be used to quantitatively measure the impact
of using different delivery methods including electroporation-
based techniques, viral-based strategies, and lipid or nanopar-
ticle-based methods.
Genome editing with engineered nucleases can be used to
create many types of changes to a genome, and any site within
an organism’s genome is now a potential target. The versatility
of this approach, combined with the ease of synthesizing new
nucleases, creates a need for a method to evaluate different
types of nucleases at different genomic locations. In this study,
we used SMRT DNA sequencing analysis to measure genome
editing at sites within the IL2RG, HBB, and CCR5 genes using
the three most widely used classes of engineered nucleases.
For the specific nucleases we investigated in K562 cells, we
found that at both the IL2RG and HBB loci the RGEN generated
significantly higher frequencies ofmutagenic NHEJ than TALENs
designed to overlapping sites. When transfected alone, the
IL2RG-specific and HBB-specific RGENs created very similar
levels of mutagenic NHEJ, suggesting that a similar amount of
DSBs are being created at the two loci. Despite this, the HBB-
specific RGEN stimulated a significantly lower frequency of
HDR than that seen at IL2RG. Whether this difference in repair
pathway utilization is the result of different chromatin status or
the sequence composition of the target sites and corresponding
donor DNA is still unclear, but this technique could be applied to
further elucidate how spatial parameters affect DNA repair. Addi-
tionally, moving between genomic loci we have encountered
single nucleotide polymorphisms (SNPs) that confound mea-
surement of NHEJ using standard mismatch detection assays
(Guschin et al., 2010), including one at HBB in K562 cells. The
ability to use SMRT DNA sequencing to quantify mutation fre-
quencies even in the presence of SNPs is another advantage
of this system.
In addition to the gamut of nucleases and target sites, molec-
ular and genetic strategies to influence DSBR pathway choice
can play a significant role in achieving a desired outcome ormini-
mizing unwanted outcomes. By titrating the amount of donor
template in K562 cells, we were able to optimize conditions for
generating HDR events and alter the ratio of HDR to NHEJ signif-
icantly. Furthermore, the long read lengths of SMRT DNA
sequencing allowed us tomeasure gene-editing outcomes using
donor templates with 800 bp arms of homology. These data
demonstrate the advantage of using long arms of homology
to stimulate higher frequencies of HDR with plasmid donors,
and this technique could further be used to directly compare
Figure 6. DNA Repair by Insertion of Large Sequences from Various Sources
(A) An event from the IL2RG RGEN-only transfections where the insert is an exact repeat—in the inverse orientation—of a sequence near the cleavage site.
(B) Reads from the IL2RGRGENand donor transfections containing inserts derived from the E. coli genome, an intronic sequence in chromosome 12, and a donor
plasmid.
(C) Several representative SMRT reads from the HBB TALENs-only transfections were recovered containing inserts derived from a repetitive genomic element,
one of the TALEN plasmids, and a region in chromosome 11 on the opposite arm from the HBB gene.
(D) Reads from the HBB RGEN and donor transfections containing inserts derived from the E. coli genome and a region in chromosome 11 on the opposite arm
from the HBB gene.
(E) Reads from the CCR5 TALENs-only transfections containing inserts derived from a TALEN plasmid and an unknown plasmid.
Wild-type (WT) sequences are shown with nuclease binding sites highlighted in yellow. Inserted sequences in the SMRT reads are lowercase and highlighted in
blue with the size and source listed below. Deleted bases, likely resulting from sequencing errors, are represented by hyphens highlighted in red. Sequence
identifiers are provided to cross-reference the Supplemental Results for further information: IL2RG_R_4, IL2RG_R+D_4, IL2RG_R+D_7, IL2RG_R+D_8,
HBB_T_1, HBB_T_3, HBB_T_5, HBB_R+D_1, HBB_R+D_3, CCR5_T_1, CCR5_T_2.
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gene-editing outcomes with different donor architectures
including plasmids, minicircle DNA, viral vectors, and ssODNs
(Chen et al., 2003, 2011; Lombardo et al., 2007). Beyond tar-
geted gene editing, this method offers an experimental system
for studying DNA repair pathway utilization when DSBs occur
at endogenous genomic loci following manipulation of DNA
repair genes. As was shown in this study, and previous studies,
parameters like nuclease properties, donor template architec-
ture, cell type, and the site being modified can influence
DSBR. The SMRT DNA sequencing method thus opens up pos-
sibilities for studying DSBR with engineered nuclease-induced
breaks, where previous work has focused significantly on breaks
induced by I-SceI at defined sites within reporter cell lines.
One area where application of SMRT DNA sequencing is chal-
lenging is the quantification of gene modifications that result in
differently sized alleles, such as when entire linear donor tem-
plates are ‘‘captured’’ by NHEJ at ‘‘on-target’’ and ‘‘off-target’’
DSBs (Cristea et al., 2013; Gabriel et al., 2011). PCR bias when
amplifying WT and modified loci with significantly different sizes
can favor shorter alleles and confound quantification, which is
further affected by loading bias for shorter molecules in the
SMRT sequencing cells. For analysis of large gene inserts medi-
ated by HDR, we have overcome this obstacle using embedded
primers that distinguish between targeted and WT allele se-
quences while producing similar PCR amplicon sizes (Voit
et al., 2014). Simultaneous measurement of amplicons with
different lengths has also been achieved by adding a size stan-
dard ladder to the SMRT sequencing reaction, and a similar
strategy could be used for quantification of large gene additions
or NHEJ-mediated integrations of the donor template (Loomis
et al., 2013).
By analyzing thousands of alleles within cell populations
modified by TALENs and CRISPRs, this technique revealed
the presence of rare insertional events where large stretches
of DNA from other sources were integrated at nuclease cleavage
sites. Choosing a cutoff of >30 bp to exclude sequences gener-
ated by DNA polymerase, we analyzed these inserted se-
quences and foundmatches to the donor template and nuclease
expression plasmids introduced for gene targeting, sequences
from nearby chromosomal sites, sites on other chromosomes,
and sites within the E. coli genome that may have originated
from trace impurities from the plasmid purification process.
The presence of these events highlights the importance of mini-
mizing the amount of exogenous DNA added for gene targeting
and illustrates the potential for SMRT DNA sequencing to mea-
sure large, rare sequence alterations at sites throughout the
genome.
The recent explosion in custom gene-editing technologies is
ushering in a new age of genome engineering where scientists
across fields of study and using different organisms and cell
types can precisely modify essentially any locus they desire.
Here, we show that SMRT DNA sequencing provides a sim-
ple, rapid, quantitative, and sensitive strategy for measuring
genome-editing outcomes with different cell lines, at any endog-
enous loci, including transcriptionally silent loci, and using
multiple nuclease platforms. Moreover, our strategy offers an
approach for studying DNA repair pathway utilization when
DNA breaks occur within genomic sites that have been difficult302 Cell Reports 7, 293–305, April 10, 2014 ª2014 The Authorsto study using previous methodologies. With the flexibility to
evaluate engineered nucleases and targeting constructs directly
at desired loci without the development of reporter systems,
SMRT DNA sequencing can streamline the development of
genome-editing projects and hasten the expansion of these
technologies to a wider range of applications.
EXPERIMENTAL PROCEDURES
Construct Assembly
IL2RG TALENs were synthesized (GenScript) using the D152 N-terminal
domain and the +63 C-terminal domain as previously described (Miller et al.,
2011) and fused to the FokI nuclease domain and cloned into pcDNA3.1 (Invi-
trogen). HBB TALENs were previously described in Voit et al. (2014). CCR5
TALENs containing the same RVDs as previously described in Mussolino
et al. (2011) were made using a Golden Gate cloning strategy (Cermak et al.,
2011) and cloned with the same N and C termini and nuclease domain into
pcDNA3.1. CCR5 ZFNs were previously described in Perez et al. (2008). For
generating RGEN expression vectors, the bicistronic expression vector
(pX330, provided by Dr. Feng Zhang, and also available through Addgene
#42230) expressing Cas9 and sgRNA were digested, and the linearized vector
was gel purified. Oligo pairs for the IL2RG and HBB sites (Table S10) were
annealed, phosphorylated, and ligated to linearized vectors.
The IL2RG, HBB, and CCR5 targeting vectors were constructed by PCR
amplifying arms of homology from the corresponding loci using genomic
DNA isolated from K562 cells. The point mutations that, upon successful
homologous recombination, would be stably integrated into the genome and
prevent binding and cleavage by the engineered nucleases were added as
part of the PCR primers used to generate the arms of homology. The homology
arms were then cloned into a 2,900 base pair vector based on pBluescript
SK+ using standard cloning methods. The full sequences of all donor con-
structs used in this study are provided in the Plasmid Sequences section of
the Supplemental Information.
Cell Culture
K562 cells (ATCC) were maintained in RPMI 1640 (HyClone) supplemented
with 10% bovine growth serum, 100 units/ml penicillin, 100 mg/ml strepto-
mycin, and 2 mM L-glutamine. Human CD34+ hematopoietic stem/progen-
itor cells (HSPCs) were purchased from Lonza (2M-101B) and thawed
per the manufacturer’s instructions. CD34+ HSPCs were maintained in
X-VIVO15 (Lonza) supplemented with SCF (100 ng/ml), TPO (100 ng/ml),
Flt3-Ligand (100 ng/ml), IL-6 (100 ng/ml), and StemRegenin1 (0.75 mM).
hESC line H1 (WiCell) was maintained in feeder-free culture conditions in
mTeSR1 (STEMCELL Technologies) on a thin layer of Matrigel (Becton Dick-
inson). Cultures were passaged every 3–5 days enzymatically with Accutase
(Innovative Cell Technologies). Cells were transfected between passage 45
and 47.
Transient Transfection for Genome Editing
K562 cells (13 106) were transfected with 2 mg TALEN-encoding plasmid and
5 mg donor plasmid (unless otherwise indicated) by nucleofection (Lonza) with
program T-016 and a nucleofection buffer containing 100 mM KH2PO4,
15 mM NaHCO3, 12 mM MgCl2 3 6H20, 8 mM ATP, 2 mM glucose (pH 7.4).
CD34+ HSPCs (4 3 105) were nucleofected with an Amaxa 4D Nucleofector
with the P3 Primary Cell Nucleofector Kit (V4XP-3032) and program EO-100
per the manufacturer’s instructions. H1 cells (1 3 106) were transfected with
0.5 or 2.5 mg of each TALEN-encoding plasmid and 4 mg donor plasmid (unless
otherwise indicated) by nucleofection (Lonza) with an Amaxa 4D Nucleofector
(program B-105) with the P3 Primary Cell Nucleofector Kit (V4XP-3032) and
following manufacturer’s instructions.
Flow Cytometry
Samples were collected 72 hr after nucleofection and analyzed for
fluorescence using an Accuri C6 flow cytometer. GFP expression was
measured using a 488 nm laser for excitation and a 530/30 band-pass filter
for detection.
Restriction Fragment Length Polymorphism Assay
Restriction fragment length polymorphism assay was performed as previ-
ously described in Chen et al. (2011). Briefly, Genomic DNA was extracted
from transfected cells with DNeasy Blood & Tissue Kit (QIAGEN). Genomic
DNA was then PCR amplified with primers flanking the donor target region
(see Table S10 for PCR primer sequences). The amplification was carried
out with Accuprime polymerase (Invitrogen), using the following cycling con-
ditions: 95C for 5 min for initial denaturation; 30 cycles of 95C for 30 s, 67C
for 45 s, and 68C for 120 s; and a final extension at 68C for 5 min. PCR
products were digested with 20 U of AfIII at 37C for 2 hr and resolved
with PAGE.
Single-Cell Clone Analysis
Single-cell cloning was performed by flow cytometry cell sorting on a BD
FACSAria. Genomic DNA was isolated from single clones using the QIAGEN
DNeasy kit (QIAGEN). The IL2RG target region was PCR amplified with Accu-
prime polymerase (Invitrogen) and the following cycling conditions: 95C for
5 min for initial denaturation; 30 cycles of 95C for 30 s, 67C for 45 s and
68C for 120 s; and a final extension at 68C for 5 min. PCR amplicons were
sequenced using standard Sanger sequencing. Sequences were analyzed
using the ApE plasmid editor by M. Wayne Davis.
SMRT Sequencing
Genomic DNA containing IL2RG alleles was harvested from cultured K562,
CD34+ HSPC, and hESC samples using the DNeasy Blood & Tissue Kit
(QIAGEN). IL2RG alleles were amplified using the primers in Table S10 with
Accuprime polymerase (Invitrogen) and the following cycling conditions:
95C for 5 min for initial denaturation; 30 cycles of 95C for 30 s, 67C for
45 s, and 68C for 60 s; and a final extension at 68C for 5 min for the K562
samples and 95C for 5 min for initial denaturation; 30 cycles of 95C for 30
s, 67C for 45 s, and 68C for 90 s; and a final extension at 68C for 5 min
for the HSPC and hESC samples. Sequencing libraries were constructed, as
previously described (Travers et al., 2010), using the DNA Template Prep Kit
1.0 (Pacific Biosciences). SMRTbell libraries contained amplicons that were
pooled together, with different barcodes appended to allowmultiplex analysis.
Purified, closed circular SMRTbell libraries were annealed with a sequencing
primer complementary to a portion of the single-stranded region of the hairpin.
For all SMRTbell libraries, annealing was performed at a final template concen-
tration between 30 and 60 nM, with a 20-fold molar excess of sequencing
primer. All annealing reactions were carried out at 80C for 2 min, with a
slow cool to 25C at a rate of 0.1C/s. Annealed templates were stored
at 20C until polymerase binding. DNA polymerase enzymes were stably
bound to the primed sites of the annealed SMRTbell templates using the
DNA Polymerase Binding Kit 2.0 (Pacific Biosciences). SMRTbell templates
(3 nM) were incubated with 6 nM of polymerase in the presence of phospho-
linked nucleotides at 30C for 2 hr. Following incubation, samples were stored
at 4C. Sequencing was performed within 72 hr of binding using final on plate
concentration of 0.3 nM. Each sample was sequenced as previously described
(Rasko et al., 2011) using DNA Sequencing Kit 2.0 (Pacific Biosciences).
Sequencing data collection was performed on the PacBio RS (Pacific Biosci-
ences) using C2/C2 chemistry and movies of 55 min in each case.
SMRT Analysis Pipeline
The SMRT Sequencing Analysis pipeline was implemented in Strawberry Perl
and utilizes the NCBI BLAST software as well as the mEmboss Needleman-
Wunsch pairwise alignment algorithm. All components of the pipeline were
run on a standard Windows PC and are available for download (https://
sourceforge.net/projects/tdna-getsmart/). Further details and description of
the pipeline are available in Supplemental Experimental Procedures SMRT
Analysis Pipeline.
Statistical Analysis
To calculate confidence intervals, t statistics were calculated as previously
described (Pattanayak et al., 2011). We calculated 90% confidence intervals
by determining the upper and lower bounds of the mutation rates that would
yield p values of 0.05, and 66% confidence intervals were calculated with a
target p value of 0.32.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, one figure, and ten tables and can be found with
this article online at http://dx.doi.org/10.1016/j.celrep.2014.02.040.
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